First-line treatment with ibrutinib plus venetoclax provided high rates of undetectable minimal residual disease in peripheral blood and bone marrow of patients with chronic lymphocytic leukemia.

Venetoclax and ibrutinib are therapeutic agents for CLL. Confirmed undetectable MRD after 12 cycles may result in treatment discontinuation. The following article features coverage from the American ...

BOISE, ID, February 6, 2025 (EZ Newswire) -- Undetectable AI, a generative artificial intelligence startup launched in 2023, just announced it has reached 15 million users. Designed to transform ...

AI writing platforms such as ChatGPT and Bard have streamlined the process of producing comprehensive articles, posts, and essays within minutes. However, the rapid advancements in AI detectors, ...